Business
Imagion (ASX:IBX) share price up 1,166% in a year pursuing ‘radiation-free’ cancer tech
The Imagion Biosystems Ltd (ASX: IBX) share price has rocketed 1,166% over the past 12 months due to a series of promising projects around cancer detection.
The company’s bio is truly a mouthful: its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and – the clincher — superparamagnetic relaxometry.
What investors should know is that it develops medical devices focused around cancer screening technology.
Imagion’s Magsense cancer screening technology
One of these tech projects, called Magsense, is a diagnostic imaging tool that can potentially increase…
-
Noosa News12 hours agoTwo in five Brisbane streets have no footpaths, with council building about 4km of new paths last year
-
Business21 hours agoWhere to invest $20,000 in ASX ETFs for 2026 and beyond
-
General20 hours agoReece Walsh grabs the Sun to lead Brisbane to an all-time victory over Canberra
-
General19 hours agoBritish boxer and former world champion Ricky Hatton dies at age 46